Template:Propranolol: Difference between revisions

Revision as of 22:11, 9 February 2014

Propranolol
Inderal LA^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Propranolol
ClinicalTrials.gov

@@ Line 2: / Line 2: @@
 ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Propranolol|{{fontcolor|#6C7B8B|Propranolol}}]]'''''
 |-
-! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Inderal LA<sup>®</sup>, InnoPran XL<sup>®</sup> FDA Package Insert
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Inderal LA<sup>®</sup> FDA Package Insert
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Propranolol indications and usage|Indications and Usage]]
@@ Line 32: / Line 32: @@
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Propranolol labels and packages|Labels and Packages]]
 |-
 ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Propranolol
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
 |-
 |}